Answers are grounded in this paper and cite their sources.
In this issue of Blood, Zhang and colleagues show evidence that many thrombocytopenic patients infected with HCV have autoantibodies specific for a defined peptide sequence in platelet membrane glycoprotein IIIa. These autoantibodies appear to be the result of an immune response mounted against one or more peptides present in the HCV core envelope protein 1.
No takes yet. Share an insight, caveat, or question.
Richard H. Aster (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: